iBio Announces Proposed Public Offering; No Amount Given

iBio, Inc.

today announced that it intends to offer shares of its common stock and common stock purchase warrants in an underwritten public offering. Roth Capital Partners, LLC is acting as the sole manager for the offering. iBio plans to use proceeds of the offering for operating costs, including continuing to develop applications of our proprietary technology, business development and for other general corporate purposes.